Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Pre-analytical practices for routine coagulation tests in European laboratories. A collaborative study from the European Organisation for External Quality Assurance Providers in Laboratory Medicine (EQALM).

Kristoffersen AH, Stavelin AV, Ajzner E, Kristensen GBB, Sandberg S, Van Blerk M, Kitchen S, Kesseler D, Woods TAL, Meijer P.

Clin Chem Lab Med. 2019 May 14. pii: /j/cclm.ahead-of-print/cclm-2019-0214/cclm-2019-0214.xml. doi: 10.1515/cclm-2019-0214. [Epub ahead of print]

PMID:
31085743
2.

Commutability of a Whole-Blood External Quality Assessment Material for Point-of-Care C-Reactive Protein, Glucose, and Hemoglobin Testing.

Bukve T, Sandberg S, Vie WS, Sølvik U, Christensen NG, Stavelin A.

Clin Chem. 2019 Jun;65(6):791-797. doi: 10.1373/clinchem.2018.300202. Epub 2019 Mar 11.

PMID:
30858160
3.

Harmonization activities of Noklus - a quality improvement organization for point-of-care laboratory examinations.

Stavelin A, Sandberg S.

Clin Chem Lab Med. 2018 Dec 19;57(1):106-114. doi: 10.1515/cclm-2018-0061.

4.

Analytical performance specifications for external quality assessment - definitions and descriptions.

Jones GRD, Albarede S, Kesseler D, MacKenzie F, Mammen J, Pedersen M, Stavelin A, Thelen M, Thomas A, Twomey PJ, Ventura E, Panteghini M; EFLM Task Finish Group – Analytical Performance Specifications for EQAS (TFG-APSEQA).

Clin Chem Lab Med. 2017 Jun 27;55(7):949-955. doi: 10.1515/cclm-2017-0151.

5.

Essential aspects of external quality assurance for point-of-care testing.

Stavelin A, Sandberg S.

Biochem Med (Zagreb). 2017 Feb 15;27(1):81-85. doi: 10.11613/BM.2017.010. Review.

6.

An overview of the European Organization for External Quality Assurance Providers in Laboratory Medicine (EQALM).

Stavelin A, Albe X, Meijer P, Sarkany E, MacKenzie F.

Biochem Med (Zagreb). 2017 Feb 15;27(1):30-36. doi: 10.11613/BM.2017.005. Review.

7.

Effect of dabigatran treatment at therapeutic levels on point-of-care international normalized ratio (INR).

Løkkebø ES, Kristoffersen AH, Stavelin A, Sølvik UØ.

Clin Chem Lab Med. 2017 Jun 27;55(7):e143-e145. doi: 10.1515/cclm-2016-0872. No abstract available.

PMID:
27816960
8.
9.

The Importance of Reagent Lot Registration in External Quality Assurance/Proficiency Testing Schemes.

Stavelin A, Riksheim BO, Christensen NG, Sandberg S.

Clin Chem. 2016 May;62(5):708-15. doi: 10.1373/clinchem.2015.247585. Epub 2016 Mar 15.

10.

[Correction: Self-management of warfarin therapy].

Sølvik UØ, Løkkebø ES, Kristoffersen AH, Stavelin AV, Binder S, Sandberg S.

Tidsskr Nor Laegeforen. 2015 Jun 16;135(11):1012. doi: 10.4045/tidsskr.15.0617. eCollection 2015 Jun 16. Norwegian. No abstract available.

11.

Self-management of warfarin therapy.

Sølvik UØ, Løkkebø ES, Kristoffersen AH, Stavelin AV, Binder S, Sandberg S.

Tidsskr Nor Laegeforen. 2015 May 19;135(9):849-53. doi: 10.4045/tidsskr.14.0768. eCollection 2015 May 19. English, Norwegian. Erratum in: Tidsskr Nor Laegeforen. 2015 Jun 16;135(11):1012.

12.

The influence of coagulation factors on the in-treatment biological variation of international normalized ratio for patients on warfarin.

Sølvik UØ, Røraas T, Petersen PH, Stavelin A, Monsen G, Sandberg S.

Scand J Clin Lab Invest. 2014 Sep;74(6):470-6. doi: 10.3109/00365513.2014.902098. Epub 2014 Apr 13.

PMID:
24724577
13.
14.

Effect of coagulation factors on discrepancies in International Normalized Ratio results between instruments.

Sølvik UØ, Røraas TH, Petersen PH, Stavelin AV, Monsen G, Sandberg S.

Clin Chem Lab Med. 2012 Mar 30;50(9):1611-20. doi: 10.1515/cclm-2011-0820.

PMID:
22962222
15.

The Accu-Chek Mobile blood glucose monitoring system used under controlled conditions meets ISO 15197 standards in the hands of diabetes patients.

Sachse D, Bolstad N, Jonsson M, Sæves I, Johansson CB, Delezuch W, Hagve M, Hardang IM, Isaksson HS, Ivarsson A, Lehto L, Keikkala E, Mattsson N, Ranta JK, Stavelin A, Sudmann AA, Varsi K.

Scand J Clin Lab Invest. 2012 Sep;72(5):374-9. doi: 10.3109/00365513.2012.677544.

PMID:
22900743
16.

External quality assessment of point-of-care International Normalized Ratio (INR) testing in Europe.

Stavelin A, Meijer P, Kitchen D, Sandberg S.

Clin Chem Lab Med. 2011 Sep 26;50(1):81-8. doi: 10.1515/CCLM.2011.719.

PMID:
21942851
17.

Discrepancies in international normalized ratio results between instruments: a model to split the variation into subcomponents.

Sølvik UØ, Petersen PH, Monsen G, Stavelin AV, Sandberg S.

Clin Chem. 2010 Oct;56(10):1618-26. doi: 10.1373/clinchem.2010.146233. Epub 2010 Aug 4.

18.

Internal quality control of prothrombin time in primary care: comparing the use of patient split samples with lyophilised control materials.

Stavelin A, Petersen PH, Sølvik U, Sandberg S.

Thromb Haemost. 2009 Sep;102(3):593-600. doi: 10.1160/TH09-02-0082.

PMID:
19718482
19.

[Choice of PT-INR instruments in primary health care].

Stavelin A, Omenås B, Bolann B, Christensen NG, Sandberg S.

Tidsskr Nor Laegeforen. 2008 Nov 20;128(22):2620. Norwegian. No abstract available.

20.

External quality assessment of prothrombin time: the split-sample model compared with external quality assessment with commercial control material.

Sølvik UØ, Stavelin A, Christensen NG, Sandberg S.

Scand J Clin Lab Invest. 2006;66(4):337-49.

PMID:
16777762
21.

[Analysis of prothrombin time in primary health care].

Trydal T, Bolann B, Brosstad F, Sandberg S, Sandset PM, Stavelin A, Steensland H, Thue G, Ødegaard OR.

Tidsskr Nor Laegeforen. 2005 Aug 11;125(15):2048-9. Norwegian. No abstract available.

Supplemental Content

Loading ...
Support Center